Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL

Cells. 2021 Oct 20;10(11):2803. doi: 10.3390/cells10112803.

Abstract

3-Poly-phosphoinositides (PIP3) regulate cell survival, division, and migration. Both PI3-kinase (phosphoinositide-3-kinase) and PTEN (phosphatase and tensin-homolog in chromosome 10) control PIP3 levels, but the mechanisms connecting PI3-kinase and PTEN are unknown. Using non-transformed cells, the activation kinetics of PTEN and of the PIP3-effector AKT were examined after the addition of growth factors. Both epidermal growth factor and serum induced the early activation of AKT and the simultaneous inactivation of PTEN (at ~5 min). This PIP3/AKT peak was followed by a general reduction in AKT activity coincident with the recovery of PTEN phosphatase activity (at ~10-15 min). Subsequent AKT peaks and troughs followed. The fluctuation in AKT activity was linked to that of PTEN; PTEN reconstitution in PTEN-null cells restored AKT fluctuations, while PTEN depletion in control cells abrogated them. The analysis of PTEN activity fluctuations after the addition of growth factors showed its inactivation at ~5 min to be simultaneous with its transient ubiquitination, which was regulated by the ubiquitin E3 ligase cCBL (casitas B-lineage lymphoma proto-oncogene). Protein-protein interaction analysis revealed cCBL to be brought into the proximity of PTEN in a PI3-kinase-dependent manner. These results reveal a mechanism for PI3-kinase/PTEN crosstalk and suggest that cCBL could be new target in strategies designed to modulate PTEN activity in cancer.

Keywords: AKT; CBL; E3 ubiquitin ligase; PTEN; phosphatidylinositide 3-kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Epidermal Growth Factor / pharmacology
  • ErbB Receptors / metabolism
  • HEK293 Cells
  • Humans
  • Mice
  • NIH 3T3 Cells
  • PTEN Phosphohydrolase / metabolism*
  • Phosphatidylinositol Phosphates / metabolism
  • Phosphorylation / drug effects
  • Platelet-Derived Growth Factor / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Proto-Oncogene Proteins c-cbl / metabolism*
  • Serum / metabolism
  • Ubiquitination / drug effects

Substances

  • Phosphatidylinositol Phosphates
  • Platelet-Derived Growth Factor
  • phosphatidylinositol 3,4,5-triphosphate
  • Epidermal Growth Factor
  • Proto-Oncogene Proteins c-cbl
  • ErbB Receptors
  • Proto-Oncogene Proteins c-akt
  • PTEN Phosphohydrolase